M&S Technologies is excited to showcase the latest innovations in vision care solutions! M&S Clinical Trial Suite, CTS consists of a variety of visual acuity and contrast sensitivity protocols that easily step the user through the eye charts presented and directly respond to user input regarding correct/incorrect results. M&S Technologies introduces the DVA-5000 for Clinical Trial ETDRS and Contrast Sensitivity Function testing. Experience the Smart System® VR Headset for reliable visual field testing, and explore the NEW Smart System 3 | 2020, now featuring patient education media. Plus, see the advanced M&S | Bruder Ocular Surface Analyzer in action. Visit us at Booth #8038
Lions World Vision Institute
Lions World Vision Institute leverages industry leading expertise, resources, and groundbreaking innovations designed to streamline cornea transplant procedures and improve clinical outcomes. Experience our latest innovations, TransplantREADY Endo-In DMEK, DSAEK and OptiGraft CAIRS during hands-on wet labs and informational presentations.
Keeler USA
Keeler is a global manufacturer of ophthalmic instruments and industry pioneer specializing in diagnostic and magnification products. Keeler’s mission is to help bring an end to preventable vision loss, delivering life-changing products and solutions to make a difference.
Jorvec Corp.
Advanced Electrophysiology and Multi-sensory Systems for Human and Rodent Models Stop by Jorvec’s booth and see our advanced visual evoked potential VEP systems and our innovative pattern electroretinogram PERG system with its unique display tablets for high rate visual stimulation and our integrated animal holder. Learn how our technologies can facilitate earlier detection and monitoring of glaucoma, LHON, TBI and other optic neuropathies. We also offer hybrid, multi-sensory systems capable of recording auditory evoked responses (ABR, AEP, OAE, VEMP), other sensory modalities (somatosensory) and event related potentials (P300), in addition to the standard visual modalities all within one device! Allow us to configure a single device capable of broad cognitive assessment. We look forward to the opportunity to discuss how our instruments and services can meet your specific animal and human research needs.
Good-Lite Company
Good-Lite has stood as an industry cornerstone for over 90 years, earning its reputation as a leading developer and manufacturer of comprehensive visual acuity testing and screening solutions. Everything about our legacy—built on trust, expertise, and innovation—drives us to continually advance methodologies, technologies, and techniques. At the heart of our mission is the early detection of visual impairments, ensuring the highest standard of care for people at every stage of life.
Evoq
EVOQ Technologies is advancing a function-first paradigm in clinical vision care through its SightGard™ platform, capturing objective retinal and neuro-visual performance using Android mobile device–based diagnostics. Its lead product, the Twilight™ Dark Adaptometer, enables rapid, standardized assessment of dark adaptation and night vision loss, supporting early detection and monitoring of retinal dysfunction across diseases including AMD, diabetic retinopathy, glaucoma, IRDs, and optic neuropathies. EVOQ focuses on repeatable, quantitative biomarkers that identify dysfunction before structural damage is visible, enabling earlier intervention and longitudinal patient monitoring. I-VIVO is EVOQ’s sister company dedicated to in vivo preclinical eye research. It develops and deploys novel structure and function instrumentation to capture high-precision data in small animal models. Capabilities include rodent contact lenses, small animal anesthesia, ERG and multi-spectral fundus imaging.
Diagnosys LLC
Diagnosys LLC offers high-throughput electrophysiology solutions for preclinical testing. The Celeris is our leading rodent and small animal testing platform for electroretinography (ERG). With Celeris, you can examine the function of each cell type along the visual pathway. Diagnosys also makes clinical systems that assist with diagnosing, monitoring, screening, and monitoring various ophthalmic conditions. Presently, our full-field stimulus test (FST) is being used as an endpoint in IRD therapy clinical trials. By popular demand, we expanded our clinical trial services to cover all phases of clinical trials. This includes initial consultation, setup, training, and expert data interpretation.